跳至主要内容
临床试验/NCT01323036
NCT01323036已完成不适用

Assessment of Bioavailability of Krill Oil Compared to Fish Oil in Healthy Volunteers

University of Manitoba1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2011年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
24
试验地点
1
主要终点
Bioavailability

研究概览

简要总结

The main purpose of the study is to evaluate the absorption of omega-3 fatty acids into the blood following consumption of krill oil compared with fish oil and placebo.

详细描述

The main purpose of the study is to evaluate the absorption of omega-3 fatty acids into the blood following consumption of krill oil compared with fish oil and placebo. An additional purpose is to evaluate the lipid-lowering efficacy and safety of consumption of Krill Oil and Fish Oil to a placebo product. It has been shown that the ingestion of Krill Oil leads to better absorption of omega-3 fatty acids compared to ingestion of Fish Oil. It was also shown that consumption of krill oil and fish oil result in a favorable modification of lipid profiles. Therefore, it is anticipated that consumption of these krill oil and fish oil will improve lipid profile, as well as other health-related markers and will be safe and well tolerated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •healthy men and premenopausal not pregnant or nursing women between 18 and 49 years old.

排除标准

  • •rheumatoid arthritis
  • •chronic illness
  • •cardiovascular problems
  • •dyslipidemia
  • •liver and kidney disease
  • •endocrine or metabolic disease
  • •inflammatory bowel disease
  • •pancreatitis
  • •gallbladder or biliary disease
  • •neurological/psychological disease
  • •bleeding disorders
  • •experienced platelet abnormalities
  • •gastrointestinal disorders that could interfere with fat absorption
  • •hypertension
  • •history of cancer
  • •an intention to lose weight
  • •use of anticoagulant
  • •serum triglycerides (TG) >200 mg/dL, and/or total cholesterol (TC) >240 mg/dL, and/or LDL-cholesterol (LDL-C) >160 mg/dL
  • •hypertension or lipid lowering medications
  • •consumption of more than one alcoholic drinks/day
  • •Consumption of more than one fish or seafood serving
  • •one month prior to the start of the study
  • •omega-6 fatty acids in the past 6 months
  • •planned to consume seafood products or fish or to use any omega-3 or omega-6 fatty acids nutritional supplements at anytime in the duration of the study
  • •planned to to become pregnant during the study period
  • •allergies to fish seafood or corn

研究组 & 干预措施

Krill Oil

Experimental

干预措施: Krill oil (Dietary Supplement)

Fish Oil

Experimental

干预措施: Fish Oil (Dietary Supplement)

结局指标

主要结局

Bioavailability

时间窗: 1 month

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Peter Jones

Director of RCFFN

University of Manitoba

研究点 (1)

Loading locations...

相似试验